This assay is to provide LoVo-based In Vivo Tumorigenesis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
LoVo
Target Cell Organism
Human
Target Cell Background
LoVo is a cell lines isolated in 1971 from the large intestine of a White, 56-year-old, male with grade IV Dukes C colorectal cancer patient. LoVo cells can be used for cancer, toxicology, and immuno-oncology research.
Related Diseases
Colorectal Adenocarcinoma; Colon Cancer
Research Area
Oncology
Assay Name
In Vivo Tumorigenesis Assay
Short Description
LoVo-cell based In Vivo Tumorigenesis Assay
Assay Description
Tumorigenicity is defined the property of a cell to form tumors when inoculated into an immunosuppressed animal model. Generally, test cells and tumor cells as positive control are administered subcutaneously into immunosuppressed nude mice. The number of animals developing tumors are compared with a positive control reference cell line.